Welcome to the upgraded BRAC University Institutional Repository. We are currently organizing collections after a recent system upgrade. Homepage category counters may temporarily show lower numbers while syncing, but over 27,000 repository items remain safe and accessible. Please use the search bar to find theses, scholarly outputs, and institutional documents.

Biosimilar in lymphoma treatment

Simple item page
bracu.degree.levelUndergraduate
bracu.type.groupStudent Works
datacite.rightsOpen Access
dc.contributor.advisorKabir, Eva Rahman
dc.contributor.authorTanisha, Mehrin Haque
dc.contributor.departmentDepartment of Pharmacy
dc.date.accessioned2021-10-25T05:47:31Z
dc.date.available2021-10-25T05:47:31Z
dc.date.copyright2021
dc.date.issued2021-04
dc.descriptionCataloged from PDF version of thesis report.
dc.descriptionIncludes bibliographical references (pages 61-72).
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.en_US
dc.description.abstractWe are living in an era where the number of ageing population is increasing, as well as the demand for treating chronic conditions like cancer, cardiovascular disease, diabetes, etc. Considering the different types of cancer, lymphoma is one of the leading causes of death, with an estimated 259,793 deaths (2.6%) in 2020. Focusing on treatment with biosimilars, this review study aims to address the Rituximab biosimilars in lymphoma care. The patent of Rituximab has expired recently, resulting in concerns for patients with regard to accessibility particularly in countries with limited funding. These challenges stimulated the development and manufacturing of Rituximab biosimilars. The review also discusses the potential advantages and impacts of Rituximab biosimilars in lymphoma patients.en_US
dc.description.degreeBachelor of Pharmacy
dc.description.statementofresponsibilityMehrin Haque Tanisha
dc.format.extent72 pages
dc.identifier.otherID 17146020
dc.identifier.urihttp://hdl.handle.net/10361/15533
dc.language.isoenen_US
dc.publisherBRAC Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectBiosimilaren_US
dc.subjectCanceren_US
dc.subjectLymphomaen_US
dc.subjectRituximaben_US
dc.subject.lcshCancer--Treatment
dc.titleBiosimilar in lymphoma treatmenten_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
17146020_PHR.pdf
Size:
1.73 MB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Project report & Thesis (Bachelor of Pharmacy)